APA (7th ed.) Citation

Reiter, F. P., Itzel, T., & Teufel, A. (2019). Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells. Cellular oncology, 42(5), . https://doi.org/10.1007/s13402-019-00458-8

Chicago Style (17th ed.) Citation

Reiter, Florian Paul, Timo Itzel, and Andreas Teufel. "Predictors of Ribociclib-mediated Antitumour Effects in Native and Sorafenib-resistant Human Hepatocellular Carcinoma Cells." Cellular Oncology 42, no. 5 (2019). https://doi.org/10.1007/s13402-019-00458-8.

MLA (9th ed.) Citation

Reiter, Florian Paul, et al. "Predictors of Ribociclib-mediated Antitumour Effects in Native and Sorafenib-resistant Human Hepatocellular Carcinoma Cells." Cellular Oncology, vol. 42, no. 5, 2019, https://doi.org/10.1007/s13402-019-00458-8.